Search results

Two new studies, one a large meta-analysis and the other real-world evidence from the UK, suggest that cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia. A new systematic review and meta-analysis, published...

The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval process. Yesterday, the Food Standards Agency (FSA) announced that its 12-week public consultation to...

Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, and clinically...

Cannabis Health will host its first expert-led educational event for healthcare professionals later this year, with a focus on bridging the gap between policy and patient access. The one-day, CPD-accredited Cannabis Health Symposium, taking place at Conway Hall in London on Tuesday 25 November...

Despite a slow start in facilitating patient access to medical cannabis treatments, this is gradually changing for the better. The UK now has an active patient base of approximately 50,000-60,000, and an estimated 80,000 individuals are expected to receive treatment with CBPMs throughout 2025...

Scientists in South Africa say they have found the first evidence of a rare class of phenolics, called ‘flavoalkaloids’, in leaves from the cannabis plant. Phenolic compounds, especially flavonoids, are well-known and sought after in the pharmaceutical industry because of their antioxidant...

A new review has found ‘consistent evidence’ that cannabis improves sexual function in women, and should be considered as a first-line treatment for patients with female orgasm disorder (FOD). After reviewing findings from 16 peer-reviewed studies, including data from over 8,000 women...

A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach. In an email sent to patients on Monday 18 August, CB1 Medical confirmed it had identified a ‘data security incident’ when patients’ personal...

A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues such as chronic pain and women’s health-related concerns. Out of 500 doctors currently practicing in the NHS, almost half of which were GPs, three quarters said that...

Ireland has become the latest jurisdiction to ban the use of the semi-synthetic cannabinoid HHC, with ministers raising concerns related to growing use among young people and risks to mental health. The decision, announced by the Department of Health on 29 July, sees Hexahydrocannabinol (HHC)...

New research on a large data set of older adults suggests cannabis use may be linked to slower brain ageing and improved cognitive function. The study, which used data collected from 25,000 adults aged between 44 and 81 years, found that those who had consumed cannabis had brain...

A new study is the first to confirm a link between an invasive fungal infection and a medical cannabis product sold to a patient in the US. A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after using a...

Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot scheme for inspiration, COVID-19, waning political will, operational hurdles, and the...

A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD. In 2022, 17.7 million people...

The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. Earlier this month the independent regulator which is responsible for overseeing...

An international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs. The worst-rated drugs were alcohol, tobacco...

The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a...

Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns about the lack of...

In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move from anecdotal patient...

Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end...